A Patient Follow-up Program to Assess Asthma Control in Patients Using Symbicort as Maintenance and Relief Therapy in a Single Inhaler (Symbicort SMART: Budesonide/Formoterol 160/4.5 Mcg, 1 or 2 Inhalations x 2 Times Plus Additional Inhalations as Needed).

Trial Profile

A Patient Follow-up Program to Assess Asthma Control in Patients Using Symbicort as Maintenance and Relief Therapy in a Single Inhaler (Symbicort SMART: Budesonide/Formoterol 160/4.5 Mcg, 1 or 2 Inhalations x 2 Times Plus Additional Inhalations as Needed).

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Jul 2009

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 10 Jul 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
    • 10 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top